GEORGE C. WILLIAMS' ANTAGONISTIC PLEIOTROPY THEORY: A GENETIC TRADE-OFF BETWEEN EARLY VIABILITY AND LATE DEGENERATION

Authors

  • Abduvaliev Anvar Arslanbekovich,Kurambaeva Jasmina Bakhodirovna PhD, Associate Professor, Department of Fundamental Medical Disciplines, Kimyo International University in Tashkent

Keywords:

antagonistic pleiotropy, aging, natural selection, reproductive success, longevity genes, p53, TOR signaling pathway, evolutionary medicine, age-related diseases.

Abstract

The Antagonistic Pleiotropy Theory (AP), proposed by George C. Williams in 1957, is the most influential evolutionary model explaining the origin of aging as a byproduct of selection for early reproductive success. In contrast to Medawar's theory of mutation accumulation, AP postulates the existence of genes (or alleles) that have multiple effects (pleiotropy), with some effects increasing fitness in early life and others decreasing survival in later life. Because the force of natural selection is greatest early in life, such alleles become fixed in the population despite their negative later effects. This review presents formal models of AP, experimental data in model organisms (Drosophila, C. elegans, mice), molecular examples of pleiotropic genes (e.g., p53, TOR, *IGF-1*, telomerase), and discusses the clinical implications of AP for understanding age-related diseases, including cancer, neurodegeneration, and metabolic syndrome. It is shown that AP not only explains aging but also predicts the existence of evolutionarily fixed "diseases of aging" as a price for early development and reproduction.

Downloads

Download data is not yet available.

References

Williams, G.C. Pleiotropy, natural selection, and the evolution of senescence. Evolution 11, 398–411 (1957).

Rose, M.R., & Charlesworth, B. A test of evolutionary theories of senescence in Drosophila. Genetics 96, 727–740 (1980).

Kirkwood, T.B.L., & Austad, S.N. Why do we age? Nature 408, 233–238 (2000).

Campisi, J. Aging, cellular senescence, and cancer. Annual Review of Physiology 75, 685–705 (2013).

Kenyon, C. The first long-lived mutants: C. elegans and the insulin/IGF-1 pathway. Cell 147, 16–22 (2011).

Johnson, A.A., et al. The role of p53 in ageing and cancer: an antagonistic pleiotropy perspective. Ageing Research Reviews 64, 101184 (2020).

Blagosklonny, M.V. TOR-driven aging: speeding car without brakes. Cell Cycle 8, 4053–4054 (2009).

Finch, C.E. The Biology of Human Longevity: Inflammation, Nutrition, and Aging in the Evolution of Lifespans. Academic Press (2007).

Austad, S.N., & Hoffman, J.M. The antagonistic pleiotropy theory of aging: a critical appraisal. The Journals of Gerontology: Series A 76, 1153–1157 (2021).

Byars, S.G., et al. Genetic loci associated with longevity in humans: a systematic review and meta-analysis. Aging Cell 20, e13450 (2021).

Downloads

Published

2026-04-24

How to Cite

Abduvaliev Anvar Arslanbekovich,Kurambaeva Jasmina Bakhodirovna. (2026). GEORGE C. WILLIAMS’ ANTAGONISTIC PLEIOTROPY THEORY: A GENETIC TRADE-OFF BETWEEN EARLY VIABILITY AND LATE DEGENERATION. Journal of Applied Science and Social Science, 16(4), 1114–1119. Retrieved from https://www.internationaljournal.co.in/index.php/jasass/article/view/4174